The Oncology Institute Announces Third Quarter 2024 Earnings Release Date and Conference Call

TOI 11.05.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-11-13
Name of Upcoming Event:Investor Relations Conference
Full Press ReleaseSEC FilingsOur TOI Tweets

About Gravity Analytica

Recent News

  • 12.19.2024 - PRESS RELEASE: Florida Blue enhances cancer care for thousands of members
  • 12.18.2024 - Florida Blue enhances cancer care for thousands of members

Recent Filings

  • 01.07.2025 - 4 Statement of changes in beneficial ownership of securities
  • 12.19.2024 - 8-K Current report
  • 12.06.2024 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
PDF Version

CERRITOS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its third quarter 2024 financial results after the market close on Wednesday, November 13, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13749308. The replay will be available until Wednesday, November 20, 2024.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website athttps://investors.theoncologyinstitute.com/.

About The Oncology Institute

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of over 1.8 million patients including clinical trials, transfusions, and other services traditionally associated with the most advanced care delivery organizations. With over 120 employed clinicians and more than 700 teammates in over 70 clinic locations, TOI is changing oncology for the better. For more information visitwww.theoncologyinstitute.com.

Investors

Solebury Strategic Communicationsinvestors@theoncologyinstitute.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com